We are live on
!
Find out more
RVM
RiverVest Venture Management Portfolio holdings
AUM
$6.84M
1-Year Est. Return
7.71%
This Fund
S&P 500
This Quarter
Est. Return
+32.96%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$86.4M
AUM Growth
+$704K
(+0.82%)
Cap. Flow
+$1.96M
Cap. Flow
% of AUM
2.27%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPRB
Spruce Biosciences
SPRB
|
+$1.95M |
| 2 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
+$12.2K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
JDR
KIM
ACM
HVM
BGC
QC
CU
PWA
RiverVest Venture Management's Q1 2023 Portfolio in Review
As of Q1 2023, RiverVest Venture Management held 6 positions worth $86.4M, up 0.82% from $85.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 0%. RiverVest Venture Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- RiverVest Venture Management added most to Spruce Biosciences in Q1 2023, an estimated $1.95M increase.
- RiverVest Venture Management's ten largest holdings make up 100% of its $86.4M portfolio in Q1 2023.
- RiverVest Venture Management opened 0 new positions and closed 0 in Q1 2023.
- RiverVest Venture Management's portfolio value rose 0.82% quarter-over-quarter to $86.4M.
Based on RiverVest Venture Management's 13F filing for Q1 2023, filed 27 Apr 2023.